Dr. Lipov received the award after presenting his research — titled “Special Operations Force protocol” — on biological treatments for special forces members with TBI and PTSD at the annual ASIPP conference, according to an April 4 news release.
The research demonstrated the use of ketamine therapy infusions and dual sympathetic reset procedures, with the results showing prolonged reduction of PTSD symptoms such as anxiety, depression and suicidal ideation after one year.
Dr. Lipov currently serves as chief medical officer of Stella, a mental healthcare company using stellate ganglion block to treat PTSD and other trauma.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.